Skip to content

Validation of a delirium monitor in postoperative elderly patients

Validation of a delirium monitor in postoperative elderly patients - Validation of delirium monitor

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON44951
Enrollment
114
Registered
2014-03-20
Start date
2014-06-25
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

confusion Delirium

Interventions

None listed

Sponsors

Intensive Care Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Aged 60 years and older Patients undergoing elective surgery in UMC Utrecht, Isala Klinieken in Zwolle, RadboudUMC in Nijmegen, or Charité Universitätmedizin in Berlin Expected to stay at least 2 days in hospital after surgery. Patients defined as frail according to the geriatrician

Exclusion criteria

Exclusion criteria: No communication possible due to language barrier or deafness Admission for neurological surgery Participation in this study during a previous hospital admission Practical or logistical reasons hampering the use of the delirium monitor Isolation because of known carrier ship of a resistant bacterium

Design outcomes

Primary

MeasureTime frame
The primary study parameters are the sensitivity, specificity, and predictive values based on the Receiver Operating Characteristics (ROC) curve of the relative delta power with as reference standard the diagnosis delirium by the delirium expert.

Secondary

MeasureTime frame
- Relative delta power vs. DRS-R-98 (measure of severity of delirium) - Relative delta power vs. VAS (0-10) likelihood for a patient to be delirious - Impact of measurement for patient based on a two-question questionnaire - Burden of measure between 0 (no burden) and 10 (unimaginable burden) - Duration of measurement between 0 (fine) and 10 (too long)

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)